BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2890599)

  • 1. Morphological studies of human endometrium during continuous LH-RH agonist treatment.
    Lundkvist O; Bergquist C
    Int J Fertil; 1986; 30(4):65-70. PubMed ID: 2890599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J
    Acta Eur Fertil; 1981 Sep; 12(3):275-6. PubMed ID: 6803498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
    Bergquist C; Nillius SJ; Wide L
    Fertil Steril; 1982 Aug; 38(2):190-3. PubMed ID: 6809500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric study of GnRH analog/HMG/HCG effects on ultrastructure of human endometrial epithelium in early and mid-luteal phase.
    Novin MG; Bazy P; Rad JS; Sarani SA; Farzadi L; Ghasemzadeh A
    J Obstet Gynaecol Res; 2007 Oct; 33(5):681-7. PubMed ID: 17845330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
    Lemay A; Jean C; Faure N
    Fertil Steril; 1987 Nov; 48(5):775-82. PubMed ID: 2959569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study.
    Fedele L; Marchini M; Bianchi S; Baglioni A; Bocciolone L; Nava S
    Obstet Gynecol; 1990 Jul; 76(1):79-84. PubMed ID: 2113661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
    Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of long-term medication with the LH-RH analogue buserelin on the regulation of the menstrual cycle (author's transl)].
    Hardt W; Schmidt-Gollwitzer M; von der Ohe M; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1981 Nov; 41(11):791-6. PubMed ID: 6797869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference in follicular maturation following acute intranasal LH-RH agonist administration during mid and late follicular phase.
    Lemay A; Faure N
    Int J Fertil; 1988; 33(1):60-7. PubMed ID: 2896176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; von der Ohe M; Nevinny-Stickel J
    Contraception; 1981 Feb; 23(2):187-95. PubMed ID: 6786826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide contraception in women. Inhibition of ovulation by chronic intranasal LRH agonist therapy.
    Bergquist C; Nillius SJ; Wide L
    Ups J Med Sci; 1984; 89(2):99-106. PubMed ID: 6431676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New observations on the physiology of menstruation.
    Flowers CE; Wilborn WH
    Obstet Gynecol; 1978 Jan; 51(1):16-24. PubMed ID: 619333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial morphology after 6 months of continuous treatment with a new gonadotropin-releasing hormone superagonist for contraception.
    Gudmundsson JA; Lundkvist O; Bergquist C; Lindgren A; Nillius SJ
    Fertil Steril; 1987 Jul; 48(1):52-6. PubMed ID: 2954864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation-inhibiting properties of Org OD 14.
    Franchimont P; Franchi F; Luisi M; Kicovic PM
    Reproduccion; 1982; 6(2):61-7. PubMed ID: 6814970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects.
    Gudmundsson JA; Bergquist C; Nillius SJ
    Prog Clin Biol Res; 1986; 225():337-51. PubMed ID: 2947248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.